Geoffrey Beran Rose - Dec 2, 2024 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
CHIEF COMMERCIAL OFFICER
Signature
/s/ Lauren Cristina, Attorney-in-Fact
Stock symbol
LUNG
Transactions as of
Dec 2, 2024
Transactions value $
-$27,065
Form type
4
Date filed
12/4/2024, 06:18 PM
Previous filing
Sep 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale -$2.43K -392 -0.13% $6.19 295K Dec 2, 2024 Direct F1
transaction LUNG Common Stock Sale -$4.26K -690 -0.23% $6.18 294K Dec 2, 2024 Direct F2
transaction LUNG Common Stock Sale -$10.9K -1.76K -0.6% $6.19 293K Dec 2, 2024 Direct F3
transaction LUNG Common Stock Sale -$9.5K -1.54K -0.53% $6.18 291K Dec 2, 2024 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021.
F2 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022.
F3 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
F4 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024.